Showing results (261-270 of 317) with videos related to
Sort By:
Pageof 32
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 12, 2020
DNA methylation in the 5-HTT regulatory region is associated with CO2-induced fear in panic disorder patientsN K Leibold, M T Weidner, C Ziegler, et al.Biochemical and Biophysical Research Communications|August 31, 1992
Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivativesM Said, D Noort, J Magdalou, et al.European Archives of Psychiatry and Clinical Neuroscience|May 19, 2026
ADHD and metabolic syndrome: behavioral and weight-related pathways to cardiovascular riskGeorg C Ziegler, Katharina Kürten, Karla Roshop, et al.AIDS (London, England)|December 4, 2020
HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotypeMaja C Ziegler, Kewreshini Naidoo, Anais Chapel, et al.Genome Research|June 3, 2011
Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experienceAmy L McGuire, Melissa Basford, Lynn G Dressler, et al.AIDS (London, England)|June 6, 2020
HIV-1 induced changes in HLA-C*03 : 04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptorsMaja C Ziegler, Annika Nelde, Jeffrey K Weber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group BMichael P DiGiovanna, David F Stern, Susan Edgerton, et al.Oncogene|September 14, 2004
Mutation of GATA3 in human breast tumorsJerry Usary, Victor Llaca, Gamze Karaca, et al.Journal of Medicinal Chemistry|May 1, 1982
Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acidsE J Cragoe, N P Gould, O W Woltersdorf, et al.Journal of Medicinal Chemistry|May 1, 1986
Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analoguesE J Cragoe, O W Woltersdorf, N P Gould, et al.Pageof 32